Aura Biosciences, Inc. Finance Lease, Weighted Average Discount Rate, Percent
Aura Biosciences, Inc. (AURA) had Finance Lease, Weighted Average Discount Rate, Percent of 7.94% as of 2021-12-31, per its 10-K filed 2023-03-15.
Discontinued › Notes › Leases
us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent · last filed 2023-03-15
- 2021-12-31: Finance Lease, Weighted Average Discount Rate, Percent 7.94%.
- 2021-09-30: Finance Lease, Weighted Average Discount Rate, Percent 7.94%.
- 2021-06-30: Finance Lease, Weighted Average Discount Rate, Percent 7.94%.
- 2021-03-31: Finance Lease, Weighted Average Discount Rate, Percent 7.94%.
| Period end | Finance Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2021-12-31 | 7.94% 10-K · filed 2023-03-15 |
| 2021-09-30 | 7.94% 10-Q · filed 2022-11-10 |
| 2021-06-30 | 7.94% 10-Q · filed 2022-08-11 |
| 2021-03-31 | 7.94% 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |